Is scenesse effective enough for vitiligo though to be a gamechager? and what proof is there that anything in “the pipeline” will work? Why only tiny safety trials after all these years? Why so much obfuscation, immature behaviour and unnecessary secrecy?
I want this company to be incredibly successful but I’m not prepared to pump and talk up indications without any evidence that they could be successful.
Way too much of that kind of behaviour has happened over these past 2 decades and thats why hardly anyone is interested in buying into the CUV “pipeline” dream.
Shorts - general info, page-719
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.69 |
Change
0.060(0.44%) |
Mkt cap ! $685.3M | |||
| Open | High | Low | Value | Volume |
| $13.63 | $13.94 | $13.59 | $674.1K | 49.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1200 | $13.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.75 | 179 | 1 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |